853
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Flecainide as first-line treatment for fetal supraventricular tachycardia

, , , , , & show all
Pages 407-412 | Received 23 Sep 2016, Accepted 20 Jan 2017, Published online: 14 Feb 2017

References

  • Southall DP, Richards J, Hardwick RA, et al. Prospective study of fetal heart rate and rhythm patterns. Arch Dis Child 1980;55:506–11.
  • Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 2011;124:1747–54.
  • Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002;19:158–64.
  • van der Heijden LB, Oudijk MA, Manten GT, et al. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. Ultrasound Obstet Gynecol 2013;42:285–93.
  • Jouannic JM, Delahaye S, Fermont L, et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat Diagn 2003;23:152–6.
  • Jaeggi E, Tulzer G. Pharmacological and interventional fetal cardiovascular treatment. In: Anderson RH, Baker EJ, Redington A, et al., eds. Paediatric cardiology. 3rd ed. Philadelphia: Elsevier; 2009:199.
  • Anderson JL, Jolivette DM, Fredell PA. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Am J Cardiol 1988;62:62D–6D.
  • Barjot P, Hamel P, Calmelet P, et al. Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis. Acta Obstet Gynecol Scand 1998;77:353–8.
  • Frohn-Mulder IM, Stewart PA, Witsenburg M, et al. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 1995;15:1297–302.
  • Strizek B, Berg C, Gottschalk I, et al. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm 2016;13:1283–8.
  • van den Heuvel F, Bink-Boelkens MT, du Marchie Sarvaas GJ, Berger RM. Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach? Pacing Clin Electrophysiol 2008;31:S54–S7.
  • Oudijk MA, Gooskens RH, Stoutenbeek P, et al. Neurological outcome of children who were treated for fetal tachycardia complicated by hydrops. Ultrasound Obstet Gynecol 2004;24:154–8.
  • Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation 2000;101:2721–6.
  • Vigneswaran TV, Callaghan N, Andrews RE, et al. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia. Heart Rhythm 2014;11:2047–53.
  • Allan LD, Chita SK, Sharland GK, et al. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991;65:46–8.
  • Krapp M, Kohl T, Simpson JM, et al. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003;89:913–7.
  • Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576–81.
  • Lasser DM, Baxi LV. Fetal response time to transplacental digoxin therapy for supraventricular tachyarrhythmia: a meta-analysis. J Matern Fetal Neonatal Med 1993;2:70–4.
  • Uzun O, Babaoglu K, Sinha A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young 2012;22:372–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.